Uz U.Günhan K.Pabuşcu Y.Mutlu S.Kamiloǧlu U.2024-07-222024-07-22202310492275http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/12063Coronavirus disease 2019 (COVID-19) is a highly contagious disease that has reached pandemic status. The diagnosis of COVID-19 is made using the polymerase chain reaction test to evaluate a swab taken from the naso/oro-pharyngeal area. Since COVID-19 is still a pandemic, it is thought that the use of this diagnostic test will be on the agenda for a while. A patient with COVID-19 symptoms presented with unilateral cerebrospinal fluid rhinorrhea after a nasopharyngeal swab test. Although nasopharyngeal swabs are taken very frequently, the complication rate is very low. However, life-threatening complications can be observed on rare occasions, and care should be taken. © 2023 Lippincott Williams and Wilkins. All rights reserved.EnglishAll Open Access; Green Open AccessCerebrospinal Fluid RhinorrheaCOVID-19COVID-19 TestingHumansNasopharynxSARS-CoV-2Specimen Handlingcerebrospinal fluid rhinorrheacoronavirus disease 2019COVID-19 testinghumannasopharynxSevere acute respiratory syndrome coronavirus 2specimen handlingArticle10.1097/SCS.0000000000009285